News Releases

Date Title and Summary View
Mar 06, 2018
Johnson & Johnson to Participate in Barclays Global Healthcare Conference
NEW BRUNSWICK, N.J. , March 6, 2018 /PRNewswire/ --  Johnson & Johnson (NYSE: JNJ) will participate in the Barclays Global Healthcare Conference on Tuesday, Mar. 13 , at the Loews Miami Beach Hotel , Miami , FL.  Joaquin Duato , Executive Vice President, Worldwide Chairman, Pharmaceuticals will
Mar 01, 2018
Johnson & Johnson Vision Announces New Digital Platform for Eye Care Professionals
JACKSONVILLE, Fla. , March 1, 2018 /PRNewswire/ -- Johnson & Johnson Vision today announced the U.S. launch of JNJVISIONPRO.COM , a digital platform that delivers online learning, patient education materials, practice resources and connected commerce - all aimed at streamlining and simplifying the
Feb 20, 2018
Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference
NEW BRUNSWICK, N.J. , Feb. 20, 2018 /PRNewswire/ --  Johnson & Johnson ( NYSE : JNJ) will participate in the Cowen 38th Annual Healthcare Conference on Tuesday, Mar. 13 , at The Boston Marriott Copley Place , Boston . Ashley McEvoy , Company Group Chairman, Consumer Medical Devices will represent
Feb 20, 2018
Feb 16, 2018
Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting
SKILLMAN, N.J. , Feb. 16, 2018 /PRNewswire/ -- Reinforcing leadership in scientifically-driven skincare, Johnson & Johnson Consumer Inc. will present eight Scientific Posters at this year's American Academy of Dermatology (AAD) Annual Meeting in San Diego , CA.  The new research spans priority
Feb 15, 2018
Health Canada Approves New Indication for ZYTIGA®* (abiraterone acetate), Broadening its Use for Treatment of Newly Diagnosed Metastatic Prostate Cancer
ZYTIGA ® , used in combination with prednisone and androgen deprivation therapy, was shown to reduce the risk of death by 38 per cent 1 TORONTO , Feb. 15, 2018 /CNW/ - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced Health Canada's approval of ZYTIGA ® (abiraterone
Feb 14, 2018
Feb 08, 2018
Johnson & Johnson to Participate in the 2018 CAGNY Conference
NEW BRUNSWICK, N.J. , Feb. 8, 2018 /PRNewswire/ --  Johnson & Johnson ( NYSE : JNJ) will participate in the 2018 CAGNY Conference on Thursday, Feb. 22 , at The Boca Raton Resort , Boca Raton , FL.  Jorge Mesquita , Executive Vice President, Worldwide Chairman, Consumer and Alison Lewis , Chief
Feb 08, 2018
Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio
NEW BRUNSWICK, N.J. , Feb. 8, 2018 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen) and Johnson & Johnson ( NYSE : JNJ) will provide a pre-recorded webcast focusing on the Phase 3 SPARTAN data for the investigational compound apalutamide in non-metastatic castration-resistant prostate
Feb 08, 2018
This site uses cookies as described in our Cookie Policy Please click the "Accept" button or continue to use our site if you agree to our use of cookies.